-
Johnson & Johnson (JNJ) Q1 2023 outcomes
Johnson&Johnson Shares fell on Tuesday after the company reported adjusted earnings and revenue that beat Wall Street expectations but lowered its sales guidance for its pharmaceuticals business. J&J, whose financial results are a guide for many healthcare companies, said its sales for the quarter rose 5.6% from the year-ago quarter. related investment news The consumer…
-
Moderna shares fall regardless of promising most cancers vaccine knowledge
Sopa Pictures | Light Rocket | Getty Images shares of Modern fell on Monday as Wall Street munched over new trial results on the personalized cancer vaccine it is developing note. Merck shares were essentially flat. The experimental mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, reduces the risk of skin cancer-melanoma recurrence by…
-
Courtroom ruling doesn’t have an effect on 17 states
A US district judge in Washington state said Thursday access to the abortion pill mifepristone was unaffected by a federal appeals court ruling that imposed restrictions on the drug this week. Judge Thomas Rice of the state’s US Eastern District last Friday ordered the Food and Drug Administration to gain access to mifepristone in 17…
-
The DOJ is asking the Supreme Court docket to dam restrictions on mifepristone
In this photo illustration, packs of mifepristone tablets are on display at a family planning clinic in Rockville, Maryland on April 13, 2023. Anna Moneymaker | Getty Images The Biden administration and abortion pill distributor Danco Laboratories on Friday asked the Supreme Court to block an order threatening access to that drug, mifepristone, in an…
-
Clinics draw up backup plans as Supreme Court docket choice looms
US suppliers of abortion pills are scrambling to make backup plans as the Supreme Court decides whether to keep restrictions on key drug mifepristone. Some personal clinics in New York, California and Kansas will offer mifepristone for now, but are preparing to offer an alternative abortion pill if a later decision essentially bans the drug.…
-
Supreme Court docket lifts restrictions on mifepristone for now
US Supreme Court Justice Samuel Alito on Friday temporarily blocked rulings by lower courts that imposed tighter restrictions on the abortion pill mifepristone. US Judge Matthew Kacsmaryk of the US Northern District of Texas last week suspended the Food and Drug Administration’s approval of mifepristone. The US 5th Circuit Court of Appeals blocked that part…
-
Florida Home passes six-week abortion ban with DeSantis backing
The Florida House of Representatives passed legislation on Thursday that would ban most abortions after six weeks when many people are unaware they are pregnant. The bill passed by a vote of 70 to 40, largely along party lines. The measure now goes to Florida Gov. Ron DeSantis, who is expected to sign it into…
-
Home Democrats are calling for an instantaneous listening to
Abortion rights supporters gather in front of the J Marvin Jones Federal Building and Courthouse on March 15, 2023 in Amarillo, Texas. Moises Avila | AFP | Getty Images Democrats on the US House Energy and Commerce Committee on Wednesday called for an immediate hearing on a federal judge’s order to suspend the Food and…
-
The ruling towards the abortion capsule places “judge-buying” issues again into the limelight
A pivotal dispute over the Food and Drug Administration’s approval of the abortion pill mifepristone has sparked new allegations of “judge shopping” by plaintiffs seeking a favorable audience for their litigation. Much of the abortion pill litigation has taken place in Amarillo, Texas, which has a federal division with only one district judge, Matthew Kacsmaryk.…
-
Texas mifepristone order threatens entry
Assistant Attorney for First Liberty Institute Matthew Kacsmaryk answers questions during his nomination hearing by the US Senate Judiciary Committee in Washington, DC, December 13, 2017, in a still from video. Reuters Attorneys general of nearly half of U.S. states warn in a new court filing that a federal judge’s decision to suspend the 23-year-old…